OMNIlife science, inc. (OMNI) is a pioneer in robotic-assisted total knee replacement, aiming to revolutionize joint replacement through a combination of tradition and innovation. The company offers OMNIBotics®, a leading robotic-assisted technology platform, as well as a range of advanced hip and knee implants to provide superior products for total joint replacement.
Founded in 1999 by a team with over 75 years of combined experience in orthopedics, OMNI is committed to enhancing surgical technique, accuracy, and efficiency for improved patient outcomes while lowering overall healthcare costs. The company is dedicated to collaboration with surgeons, leveraging innovative engineering and a relentless pursuit of objectives to achieve these goals.
OMNI's mission centers on improving patient satisfaction and outcomes while simultaneously reducing costs for the healthcare system. The company is privately held and based in Raynham, MA, positioning it at the forefront of medical devices, robotics, and manufacturing within the healthcare industry.